Medicina
DEPARTAMENTO
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (40)
2024
-
β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury
Basic Research in Cardiology, Vol. 119, Núm. 5, pp. 773-794
2023
-
Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney
Redox Biology, Vol. 68
-
MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM)
Nature Communications, Vol. 14, Núm. 1
2022
-
Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics
Basic Research in Cardiology, Vol. 117, Núm. 1
2021
-
Sustained elevated blood pressure accelerates atherosclerosis development in a preclinical model of disease
International Journal of Molecular Sciences, Vol. 22, Núm. 16
2020
-
A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
Cell, Vol. 183, Núm. 1, pp. 94-109.e23
-
Does the right ventricle experiment morphologic and functional changes similarly to the left ventricle during pregnancy?
Echocardiography, Vol. 37, Núm. 6, pp. 850-857
-
The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis
Scientific Reports, Vol. 10, Núm. 1
2019
-
Adult sox10+ Cardiomyocytes Contribute to Myocardial Regeneration in the Zebrafish
Cell Reports, Vol. 29, Núm. 4, pp. 1041-1054.e5
-
Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson–Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite
Aging Cell, Vol. 18, Núm. 3
2018
-
Cardiomyocyte- and not endothelial-specific (β3-adrenergic receptor stimulation protects the heart against ischemia/reperfusion injury (Póster)
Journal of the American College of Cardiology, Vol. 71, Núm. 11 suplemento, pp. A8
-
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318
-
Tbx5a lineage tracing shows cardiomyocyte plasticity during zebrafish heart regeneration
Nature Communications, Vol. 9, Núm. 1
2017
-
Neutrophil stunning by metoprolol reduces infarct size
Nature Communications, Vol. 8
2016
-
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
Basic Research in Cardiology, Vol. 111, Núm. 4
-
Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations
Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Núm. 46, pp. E7250-E7259
2015
-
Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2
Journal of the American College of Cardiology, Vol. 65, Núm. 14, pp. 1438-1450
-
Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: New insights from a comprehensive translational study
Journal of the American Heart Association, Vol. 4, Núm. 1
-
Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35, Núm. 1, pp. 50-59
-
Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study
Circulation, Vol. 131, Núm. 24, pp. 2104-2113